Leptin signaling maintains B-cell homeostasis via induction of Bcl-2 and cyclin D1

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 31, 2010, Pages 13812-13817

  Lam, Queenie Lai Kwan ^a   Wang, Shengjun ^b   Ko, Otis King Hung ^a   Kincade, Paul W ^c   Lu, Liwei ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b JIANGSU UNIVERSITY   (China)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Apoptosis; B cell survival; microRNA; Proliferation

Indexed keywords

CYCLIN D1; LEPTIN; PROTEIN BNIP3; CCND1 PROTEIN, MOUSE; LEPTIN RECEPTOR; LEPTIN RECEPTOR, MOUSE; MICRORNA; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL CYCLE PROGRESSION; CELL SURVIVAL; GENE AMPLIFICATION; HOMEOSTASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; 3' UNTRANSLATED REGION; ANIMAL; C57BL MOUSE; CELL LINE; CELL PROLIFERATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PROMOTER REGION;

3' UNTRANSLATED REGIONS; ANIMALS; B-LYMPHOCYTES; CELL LINE; CELL PROLIFERATION; CYCLIN D1; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, LEPTIN; SIGNAL TRANSDUCTION;

EID: 77956373481     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1004185107     Document Type: Article

References (27)

1. Rathmell JC, Thompson CB (2002) Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 109 (Suppl):S97-S107. (Pubitemid 34457855)
2. Hildeman D, Jorgensen T, Kappler J, Marrack P (2007) Apoptosis and the homeostatic control of immune responses. Curr Opin Immunol 19:516-521. (Pubitemid 47464912)
3. Marsden VS, Strasser A (2003) Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu Rev Immunol 21:71-105.
4. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ (1993) Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229-240.
5. McDonnell TJ, et al. (1989) Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57:79-88.
6. Piatelli MJ, Tanguay D, Rothstein TL, Chiles TC (2003) Cell cycle control mechanisms in B-1 and B-2 lymphoid subsets. Immunol Res 27:31-52.
7. Kondo E, et al. (1994) Expression of Bcl-2 protein and Fas antigen in non-Hodgkin's lymphomas. Am J Pathol 145:330-337. (Pubitemid 24245833)
8. Qi CF, et al. (1998) Expression of cyclin D1 in mouse B cell lymphomas of different histologic types and differentiation stages. Leuk Res 22:395-404.
9. Calin GA, et al. (2004) MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 101:11755-11760.
10. Lam QL, Zheng BJ, Jin DY, Cao X, Lu L (2007) Leptin induces CD40 expression through the activation of Akt in murine dendritic cells. J Biol Chem 282:27587-27597. (Pubitemid 47529530)
11. Lam QL, Lu L (2007) Role of leptin in immunity. Cell Mol Immunol 4:1-13.
12. Lo CK, et al. (2009) Leptin signaling protects NK cells from apoptosis during development in mouse bone marrow. Cell Mol Immunol 6:353-360.
13. Mancuso P, et al. (2002) Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J Immunol 168:4018-4024.
14. Busso N, et al. (2002) Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 168:875-882.
15. Skibola CF, et al. (2004) Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 13:779-786.
16. Pamuk GE, et al. (2006) Leptin and resistin levels in serum of patients with hematologic malignancies: Correlation with clinical characteristics. Exp Oncol 28:241-244.
17. Cai C, Shi FD, Matarese G, La Cava A (2009) Leptin as clinical target. Recent Pat Inflamm Allergy Drug Discov 3:160-166.
18. Chou WC, Levy DE, Lee CK (2006) STAT3 positively regulates an early step in B-cell development. Blood 108:3005-3011.
19. Mazumder B, Seshadri V, Fox PL, et al. (2003) Translational control by the 3′-UTR: the ends specify the means. Trends Biochem Sci 28:91-98.
20. Tusche MW, et al. (2009) Differential requirement of MALT1 for BAFF-induced outcomes in B cell subsets. J Exp Med 206:2671-2683.
21. Patke A, Mecklenbräuker I, Erdjument-Bromage H, Tempst P, Tarakhovsky A (2006) BAFF controls B cell metabolic fitness through a PKC beta- and Akt-dependent mechanism. J Exp Med 203:2551-2562.
22. Grivennikov SI, KarinM(2009) Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 21:11-19.
23. Gold MR (2003) Akt is TCL-ish: Implications for B-cell lymphoma. Trends Immunol 24:104-108.
24. Baumann H, et al. (1996) The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc Natl Acad Sci USA 93:8374-8378.
25. Klöting N, et al. (2009) MicroRNA expression in human omental and subcutaneous adipose tissue. PLoS ONE 4:e4699.
26. Bodrug SE, et al. (1994) Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 13:2124-2130.
27. Lam QL, Liu S, Cao X, Lu L (2006) Involvement of leptin signaling in the survival and maturation of bone marrow-derived dendritic cells. Eur J Immunol 36:3118-3130.